Prices plus VAT plus shipping costs
Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt
- Order number: EP09861_1
Myelin oligodendrocyte glycoprotein (MOG) 35-51, a minor component of CNS myelin, is expressed... more
Product information "MOG 35 - 51"
Myelin oligodendrocyte glycoprotein (MOG) 35-51, a minor component of CNS myelin, is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 35-51 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG (35-51) peptide can be use to induced polyclonal anti-MOG(35-51) antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG (35-51) suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP.
|Protein:||Myelin oligodendrocyte glycoprotein|
|Application :||Multiple Sclerosis|
Dokumente - Protokolle - Downloads more
Protocols and Tips
Safety data sheets